Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
, , y
03 mar 2019
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 03 mar 2019
Páginas: 85 - 95
Recibido: 30 ago 2018
Aceptado: 20 sept 2018
DOI: https://doi.org/10.2478/raon-2019-0013
Palabras clave
© 2019 Martina Rebersek, Tanja Mesti, Marko Boc, Janja Ocvirk, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Rebersek, Martina
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Mesti, Tanja
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Boc, Marko
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Ocvirk, Janja
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia